Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chouhan, Surbhi ^a   Singh, Snahlata ^a   Athavale, Dipti ^a   Ramteke, Pranay ^a   Pandey, Vimal ^a,b   Joseph, Jomon ^a   Mohan, Rajashekar ^c   Shetty, Praveen Kumar ^c   Bhat, Manoj Kumar ^a  

^a UNIVERSITY OF PUNE   (India)

^b UNIVERSITY OF HYDERABAD   (India)

^c SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; DKK4 PROTEIN, HUMAN; GLUCOSE; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ANIMAL; CELL PROLIFERATION; COMPLICATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN; GENETICS; GLYCEMIC INDEX; HEP-G2 CELL LINE; HUMAN; HYPERGLYCEMIA; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; WNT SIGNALING;

ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLYCEMIC INDEX; HEP G2 CELLS; HUMANS; HYPERGLYCEMIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MICE; RNA, SMALL INTERFERING; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84974605180     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27558     Document Type: Article

References (53)

1. Ferenci, P. et al. Hepatocellular carcinoma (HCC): A global perspective. J. Clin. Gastroenterol. 44, 239-245 (2010).
2. Liu, C. J. & Kao, J. H. Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J. Semin. Liver Dis. 33, 92-102 (2013).
3. Venook, A. P., Papandreou, C., Furuse, J. & De Guevara, L. L. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist 15, 5-13 (2010).
4. Wang, P., Kang, D., Cao, W., Wang, Y. & Liu, Z. Diabetes mellitus and risk of hepatocellular carcinoma: A systematic review and meta-analysis. Diabetes Metab. Res. Rev. 28, 109-122 (2012).
5. Tolman, K. G., Fonseca, V., Dalpiaz, A. & Tan, M. H. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 30, 734-743 (2007).
6. Sinha, A. et al. Population based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune City. Current Science 105, 486-491 (2013).
7. Angulo, P. et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterol. 145, 782-789 (2013).
8. Fedirko, V. et al. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in western europeans. Ann. Oncol. 24, 543-553 (2013).
9. Jiang, C. M. et al. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J. Gastroenterol. 20, 16464-16473 (2014).
10. Farrell, G. C., Van Rooyen, D., Gan, L. & Chitturi, S. NASH is an inflammatory disorder: Pathogenic, prognostic and therapeutic implications. Gut Liver 6, 149-171 (2012).
11. Lukanova, A. et al. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: Etiological factors or risk markers? Int. J. Cance. 134, 164-173 (2014).
12. Chao, L. T. et al. Insulin, glucose, and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort. Carcinogenesis 32, 876-881 (2011).
13. Hosokawa, T. et al. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J. Gastroenterol. 19, 249-257 (2013).
14. Donadon, V., Balbi, M., Valent, F. & Avogaro, A. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J. Gastroenterol. 16, 3025-3032 (2010).
15. Lagiou, P. et al. Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection. Ann. Oncol. 20, 1741-1745 (2009).
16. Hung, C. L. et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl. Acad. Sci. 111, 18697-18702 (2014).
17. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
18. Suarez, M. I. et al. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Ann. Hepatol. 14, 64-74 (2015).
19. Zucman-Rossi, J. et al. Genotype-phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC. Hepatology 43, 515-524 (2006).
20. Vilarinho, S. et al. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations. J. Hepatol. 61, 1178-1183 (2014).
21. White, B. D. et al. Dysregulation of Wnt-catenin signaling in gastrointestinal cancers. Gastroenterol. 142, 219-232 (2012).
22. García-Jiménez, C., García-Martínez, J. M., Chocarro-Calvo, A. & De la Vieja, A., A. new link between diabetes and cancer: Enhanced WNT/?-catenin signaling by high glucose. J. Mol. Endocrinol. 52, 51-66 (2013).
23. Mi-Hyun, K., Seung-Hyun, H. & Moon Kyu, L. Insulin Receptor-Overexpressing β-Cells Ameliorate Hyperglycemia in Diabetic Rats through Wnt Signaling Activation. PLoS One 8, e67802 (2013).
24. Brabletz, T., Jung, A., Dag, S., Hlubek, F. & Kirchner, T. ?-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155, 1033-1038 (1999).
25. Chocarro-Calvo, A., García-Martínez, J. M., Ardila-González, S., De la Vieja, A. & García-Jiménez, C. Glucose-induced catenin acetylation enhances Wnt signaling in cancer. Mol. Cell 49, 474-486 (2013).
26. Vaira, S., Friday, E., Scott, K., Conrad, S. & Turturro, F. Wnt-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231. Journal Cell Physiol. 227, 578-586 (2012).
27. Anagnostou, S. & Shepherd, P. Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines. Biochem. J. 416, 211-218 (2008).
28. Krupnik, V. E. et al. Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313 (1999).
29. Fatima, S., Luk, J. M., Poon, R. T. & Lee, N. P. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. Expert Rev. Mol. Diagn. 14, 535-548 (2014).
30. Chen, L., Li, M., Li, Q., Wang, C. J. & Xie, S. Q. DKK1 promotes hepatocellular carcinoma cell migration and invasion through betacatenin/MMP7 signaling pathway. Mol. Cancer 12, 157-171 (2013).
31. Sato, H. et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28, 2459-2466 (2007).
32. Fatima, S. et al. Dickkopf 4 (DKK4) acts on Wnt-catenin pathway by influencing ?-catenin in hepatocellular carcinoma. Oncogene 31, 4233-4244 (2012).
33. Mano, Y. et al. Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma. Am. J. Clin. Pathol. 142, 391-397 (2014).
34. Liu, C. et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-47 (2002).
35. Li, C. I. et al. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes-"National cohort of Taiwan Diabetes Study. Int. J. Cancer 136, 2668-2679 (2015).
36. Zelber-Sagi, S. et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J. Hepatol. 47, 711-717 (2007).
37. Laguna, J. C., Alegret, M. & Roglans, N. Simple sugar intake and hepatocellular carcinoma: Epidemiological and mechanistic insight. Nutrients 6, 5933-5954 (2014).
38. Dang, C. V. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb. Perspect Med. 1, 3 (2013).
39. Wang, H. et al. c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27, 1905-1915 (2008).
40. Briata, P., Laurino, C. & Gherzi, R. c-myc gene expression in human cells is controlled by glucose. Biochem. Biophys. Res. Commun. 165, 1123-1131 (1989).
41. Chakraborty, A. A. et al. A common functional consequence of tumor-derived mutations within c-MYC. Oncogene 34, 2406-2409 (2015).
42. Lin, C. P., Liu, C. R., Lee, C. N., Chan, T. S. & Liu, H. E. Targeting c-Myc as a novel approach for hepatocellular carcinoma. World J. Hepatol. 2, 16-20 (2010).
43. Yuen, M. F., Wu, P. C., Lai, V. C., Lau, J. Y. & Lai, C. L. Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer 91, 106-112 (2001).
44. Miller, D. M., Thomas, S. D., Islam, A., Muench, D. & Sedoris, K. c-Myc and cancer metabolism. Clin. Cancer Res. 18, 5546-5553 (2012).
45. Monga, S. P. Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterol. 148, 1294-1310 (2015).
46. Liao, C. H. et al. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Hepatology 55, 910-920 (2012).
47. Niehrs, C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25, 7469-7481 (2006).
48. Pandey, V., Chaube, B. & Bhat, M. K. Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells. J. Cell. Biochem. 112, 2942-2952 (2011).
49. Upadhay, A. K. et al. Methyl-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: Involvement of Akt, NF-?B and Bcl-2. Toxicol. Appl. Pharmacol. 216, 177-185 (2006).
50. Vijayakumar, M. V., Pandey, V., Mishra, G. C. & Bhat, M. K. Hypolipidemic effect of fenugreek seeds is mediated through inhibition of fat accumulation and upregulation of LDL receptor. Obesity 18, 667-674 (2010).
51. Uematsu, K. et al. Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression. Oncogene 22, 7218-7221 (2003).
52. Mohammad, N. et al. Cholesterol depletion by methyl-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol. Cancer 13, 4598-4613 (2014).
53. Singh, S. & Bhat, M. K. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factorkappaB in human HPV-18 E6-positive HEp-2 cells. Biochem. Biophys. Res. Commun. 318, 346-353 (2004).